| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.46 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.17 | 0.1 |